|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Review On Breast Cancer And It’s Treatment : Capivasertib and combination with fulvestrant |
| Authors Name: | Gaikwad Nikita Prakash , Gajare Asawari Sham |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_213148
|
| Published Paper Id: | IJNRD2401308 |
| Published In: | Volume 9 Issue 1, January-2024 |
| DOI: | |
| Abstract: | This study has been undertake A Bosom disease, or breast cancer, is a malignant tumor that develops from breast cells. It can originate in different parts of the breast, including the ducts that carry milk to the nipple or the glands that produce milk. Over time, these cancerous cells can invade nearby tissues and spread to other parts of the body. More than half of bosom growths harbor modifications in at least one qualities of the phosphatidylinositol 3-kinase (PI3K) pathway including PIK3CA changes (31%), PTEN misfortune (34%), PTEN transformations (5%) and AKT1 transformations (3%). While PI3K and mTOR inhibitors are as of now endorsed in cutting edge bosom disease, AKT inhibitors have been as of late evolved as another restorative methodology. Capivasertib (AZD5363) is a novel, specific ATP-cutthroat skillet AKT kinase inhibitor that applies comparable action against the three AKT isoforms, AKT1, AKT2, and AKT3 |
| Keywords: | Breast cancer, Capivasertib, fulvestrant, biomarkers ,immunomodulation . |
| Cite Article: | "Review On Breast Cancer And It’s Treatment : Capivasertib and combination with fulvestrant ", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 1, page no.d66-d73, January-2024, Available :http://www.ijnrd.org/papers/IJNRD2401308.pdf |
| Downloads: | 000118766 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2401308 Registration ID: 213148 Published In: Volume 9 Issue 1, January-2024 DOI (Digital Object Identifier): Page No: d66-d73 Country: Ahmednagar , MAHARASHTRA, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2401308 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2401308 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn